Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;20(6):1546-1583.
doi: 10.1038/s41596-024-01090-z. Epub 2024 Dec 15.

Precise kilobase-scale genomic insertions in mammalian cells using PASTE

Affiliations
Review

Precise kilobase-scale genomic insertions in mammalian cells using PASTE

Christopher W Fell et al. Nat Protoc. 2025 Jun.

Abstract

Programmable gene integration technologies are an emerging modality with exciting applications in both basic research and therapeutic development. Programmable addition via site-specific targeting elements (PASTE) is a programmable gene integration approach for precise and efficient programmable integration of large DNA sequences into the genome. PASTE offers improved editing efficiency, purity and programmability compared with previous methods for long insertions into the mammalian genome. By combining the specificity and cargo size capabilities of site-specific integrases with the programmability of prime editing, PASTE can precisely insert cargoes of at least 36 kb with efficiencies of up to 60%. Here we outline best practices for design, execution and analysis of PASTE experiments, with protocols for integration of EGFP at the human NOLC1 and ACTB genomic loci and for readout by next generation sequencing and droplet digital PCR. We provide guidelines for designing and optimizing a custom PASTE experiment for integration of desired payloads at alternative genomic loci, as well as example applications for in-frame protein tagging and multiplexed insertions. To facilitate experimental setup, we include the necessary sequences and plasmids for the delivery of PASTE components to cells via plasmid transfection or in vitro transcribed RNA. Most experiments in this protocol can be performed in as little as 2 weeks, allowing for precise and versatile programmable gene insertion.

PubMed Disclaimer

Conflict of interest statement

Competing interests: C.W.F., C.S.-U., J.S.G. and O.O.A. are inventors on patent applications related to CRISPR technologies. O.O.A. and J.S.G. are co-founders of Sherlock Biosciences, Doppler Biosciences, Circle Labs and Tome Biosciences.

References

    1. Sheridan, C. The world’s first CRISPR therapy is approved: who will receive it? Nat. Biotechnol. 42, 3–4 (2024). - PubMed - DOI
    1. Veit, G. et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol. Biol. Cell 27, 424–433 (2016). - PubMed - PMC - DOI
    1. Ausländer, S. & Fussenegger, M. Engineering gene circuits for mammalian cell-based applications. Cold Spring Harb. Perspect. Biol. 8, a023895 (2016). - PubMed - PMC - DOI
    1. Tou, C. J. & Kleinstiver, B. P. Recent advances in double-strand break-free kilobase-scale genome editing technologies. Biochemistry 62, 3493–3499 (2023). - PubMed - DOI
    1. Suzuki, K. et al. In vivo genome editing via CRISPR–Cas9-mediated homology-independent targeted integration. Nature 540, 144–149 (2016). - PubMed - PMC - DOI

Publication types

Substances

Associated data

LinkOut - more resources